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Walter J. Paulus, MD, PhD, associate director of the Cardiovascular Center, Aalst,
Belgium, and professor of cardiac pathophysiology at the VU University Medical
Center, Amsterdam, the etherlands, talks to Barry Shurlock, MA, PhD.
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Spotlight:Walter J. Paulus, MD, PhD
“Diastolic Heart Failure Is Clearly a Consequence of Affluence and
‘Overindulgence’ in Western Countries, and There Is a Suspicion That
It Is Correctable and Reversible”
One day in 2004, Attila Borbély, MD, a Hungarianresearch fellow working on isolated cardiomyocytes
in the Department of Physiology at the VU University
Medical Centre, Amsterdam, the Netherlands, consulted
his supervisor, Walter J. Paulus, MD, PhD, associate direc-
tor of the Cardiovascular Center, Aalst, Belgium, and pro-
fessor of cardiac pathophysiology at the VU University
Medical Center, with concerns that his study of isolated
cardiomyocytes was bedeviled by an artefact. He was
investigating the direct effects of nitrates on cardiomy-
ocytes of patients with heart failure by carrying out resting
force and sarcomere length measurements on biopsy sam-
ples taken before and after treatment. The problem was, he
thought, that, although cardiomyocytes from patients with
systolic heart failure stretched in a normal manner, those
from patients with diastolic heart failure had a high resting
force and were unusually stiff. His boss greeted his find-
ings with delight. Since the late 1970s, Professor Paulus
had been aware that diastolic heart failure differed from its
systolic twin, probably as a consequence of the stiffness of
the heart muscle. At last, he had proof at the cellular level.
Since then, Professor Paulus and his team at the VU
University Medical Center have taken the story further. He
says, “By carrying out force/extension measurements with
single cells, we have shown that cardiomyocytes have a
high passive tension, reflecting the overall phenotype of
the heart. Moreover, we have shown that this stiffness can
On other pages...
be reversed in vitro with protein kinases. The stiffness in
the cardiomyocyte is known to be due to a single protein,
titin, which is the largest polypeptide known. It is an
extremely complex molecule with 224 individually folded
protein domains and acts like a bidirectional spring.
“Titin covers the complete sarcomere in cardiac mus-
cle, and we have been the first to show that in diastolic
heart failure a lack of titin phosphorylation renders the car-
diomyocytes stiff.1 Both protein kinase A and protein
kinase G can phosphorylate titin. The ability of protein
kinase G to do this explains our earlier work showing that
nitric oxide (NO) increases diastolic distensibility because
protein kinase G sits in the NO cascade. Also, working with
myocardial biopsy material of patients with diastolic heart
failure, we have shown that active protein kinase G needs
a cofactor, cyclic guanosine monophosphate (GMP). Cyclic
GMP is produced by soluble guanylate cyclase, whose activ-
ity is controlled by NO. As a result of low NO bioavailabil-
ity, cyclic GMP is 8 times lower in the myocardium of
patients with diastolic heart failure. The low bioavailabili-
ty of NO is related to high oxidative stress associated with
obesity or diabetes. Excess free radicals in the presence of
high oxidative stress inactivate NO, reducing cyclic GMP
and leading to diastolic heart failure.
“These ideas are exciting, but we still have to establish
the link with obesity. Essentially, we regard diastolic heart
failure as a consequence of obesity-induced endothelial
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dysfunction. There is still no effective treatment, but it
seems clear that approaches that need to be examined
include risk factor control, use of the appropriate antioxida-
tive agents (results with vitamins A and E have been frus-
trating), measures to prevent the breakdown of the cofactor
cyclic GMP (perhaps with sildenafil), and reassessment of
the use of angiotensin-converting enzyme inhibitors
because they have NO-releasing properties.”
“This Article Demonstrated a Continuous Decline of
Left Ventricular Pressure During Diastole and
Supported the otion That the Resting Phase of the
Cardiac Cycle Was Dynamic”
Professor Paulus’s study of cardiac cells began >30 years
ago when he was at medical school in his hometown of
Antwerp, Belgium. He says, “I was fortunate to work with
the distinguished physiologist Professor Dirk L. Brutsaert,
MD, PhD (see http://circ.ahajournals.org/content/124/11/
f61.full.pdf+html). He was extremely stimulating, and in my
first year asked any undergraduate who was interested in
doing some research to contact him. So I did, and I worked
in the lab on isolated muscle strips, 2 days a week during term
time and even more in the holidays. This chance encounter
with Dirk Brutsaert shaped my entire career, and it still does.”
After studying internal medicine, Professor Paulus
worked as a cardiology fellow. By age 28, his research had
made him first author of 3 articles published in Circulation
Research. Then in 1979, he became a Fogarty International
Fellow to Brigham and Women’s Hospital, Boston, MA.
He says, “I benefited from the tail end of the Marshall Plan
(European Recovery Programme) brought in after the war
and funded by the National Institutes of Health. At
Harvard, my mentor was Bill (William) Grossman, MD,
who was director of the cardiac catheterisation lab. He was
already aware that in diastolic heart failure contraction is
normal, but a dysfunction in cardiac muscle makes the heart
stiff. I was not yet an accredited cardiologist, so I worked as
a research fellow and a clinical fellow. It was an incredibly
stimulating place to be. Eugene Braunwald, MD, and Tom
Smith, MD, were both there. The group of cardiology fel-
lows I was with have all gone on to hold major positions,
such as Peter Libby, MD, Marvin Konstam, MD, Marc
Pfeffer, MD, Samuel Goldhaber, MD, Richard Nesto, MD,
Morton Kern, MD, and John Horowitz, MD. In retrospect,
although the research was important, perhaps the most
important thing about such a fellowship is that you estab-
lish a network of people in the same field.”
The research in the United States did, however, result in
an article that Professor Paulus considers to be 1 of his
most important, albeit as second author, namely, a demon-
stration of improved diastolic function and systolic per-
formance in hypertrophic cardiomyopathy after adminis-
tration of the calcium channel blocker nifedipine.2 He says,
“This article demonstrated a continuous decline of left ven-
tricular pressure during diastole and supported the notion
that the resting phase of the cardiac cycle was dynamic.”
“We Increasingly Realised That Diastolic Heart
Failure Is Related to Type 2 Diabetes Mellitus,
Obesity, and Hypertension”
After his fellowship, Professor Paulus was offered a posi-
tion in San Francisco, CA, but he says, “I had to give up my
American Dream and serve for 14 months as a lieutenant at
a military hospital in Brussels, working as a cardiologist”
because military service in Belgium was obligatory under
agreements with the North Atlantic Treaty Organisation.
Professor Paulus was then invited to take up a position as a
cardiologist at the newly formed Cardiovascular Center on
the campus of the Onze-Lieve-Vrouwziekenhuis at Aalst,
where he continued with his research on diastolic heart fail-
ure while taking on a heavy clinical load of routine cardi-
ology and interventional procedures. Since 1984, he has
been associate director of the division, which is now the
second largest cardiac centre in Belgium.
In 1994, Professor Paulus published another landmark
article, which showed that NO has acute effects on left ven-
tricular relaxation and diastolic distensibility.3 This finding
was to be better understood as his research unfolded the
mechanisms of diastolic heart failure. He says, “Rather
than regarding diastolic heart failure as an unusual form of
heart failure, different, for example, from postmyocardial
heart failure, we increasingly realised that it was prevalent
and related to type 2 diabetes mellitus, obesity, and hyper-
tension. The latest statistics from the Mayo Clinic
(Rochester, MN) show that it accounts for ≈50% of all
heart failure and is increasing every year.
“Diastolic heart failure is clearly a consequence of
affluence and ‘overindulgence’ in Western countries, and
there is a suspicion that it is correctable and reversible.
There is some evidence in this direction, but we still have
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Left, Professor Paulus with his longstanding clinical collaborator, Jean Bronzwaer, MD,
PhD, in the isolated cardiomyocyte lab of the VU University Medical Center, Amsterdam,
the !etherlands, where Professor Paulus has been professor of physiology since 2003.
The university (above) was founded in 1880 by the Calvinist politician Abraham Kuyper,
who was the Dutch prime minister between 1901 and 1905, and has ≈27,000 students in
all faculties. Photographs courtesy of Professor Paulus.
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to prove it. Recent work has shown, for example, that you
can alleviate diastolic heart failure with an exercise training
programme. This is an important message because heart fail-
ure overall is 1 of the most frequent reasons for hospitalisa-
tion and is a huge economic burden. Lifestyle changes will
probably be effective, but we need to note that there are sub-
tle differences in the consequences in terms of macro- and
microvascular complications of unhealthy habits. In dias-
tolic heart failure, the microvascular changes are most sig-
nificant. This explains why diastolic left ventricular dys-
function correlates with erectile dysfunction.”4 He adds,
“Recent evidence from Italian workers suggests that silde-
nafil is beneficial for diastolic heart failure.”5
In 2003, Professor Paulus took up an additional appoint-
ment as professor of cardiac pathophysiology at the VU
University Medical Center in Amsterdam, 200 km from
Aalst (Dutch is his native language, although he also speaks
French, English, and German). In this role, he is coordinat-
ing the Metabolic Road to Diastolic Heart Failure
(MEDIA) research project involving 18 centres throughout
the European Union to unravel the links between
“lifestyle” and the epidemic of diastolic heart failure in eld-
erly people, which has received funding of €12 million
from the European Commission’s Seventh Framework
Programme (see http://circ.ahajournals.org/content/123/25/
f145.full.pdf+html). He says, “In 2009, the European
Commission called for proposals for a large project on
diastolic heart failure. I contacted people around Europe,
and we met at Schiphol Airport (Amsterdam) to put together
a proposal to be coordinated from the VU University
Medical Center, which we submitted in November 2009. It
was accepted the following March, signed off in December,
and started in 2011 with the first tranche of 3 million Euros.
The rest of the funding will be provided in stages based on
our reports of ‘deliverables.’ It is important that we estab-
lish an animal model of diastolic heart failure to prove that
metabolic factors are causal. We also need to find more
firm diagnostic criteria. We are therefore looking for bio-
markers in the blood that reflect oxidative stress, low NO
bioavailability, or other determinants of myocardial stiff-
ness. Finally, we have to come up with a comprehensive
treatment programme.” Professor Paulus and colleagues
from Portugal (University of Porto) and Hungary
(University of Debrecen) have already shown that diabetes
mellitus worsens diastolic left ventricular dysfunction in
aortic stenosis by altering the structure of the myocardium
and increasing cardiomyocyte stiffness.6
Professor Paulus’s other professional activities have
included serving on the board of the Heart Failure Association
of the European Society of Cardiology and as chair of the
European Society of Cardiology Working Group on
Myocardial Function. Together with Otto Smiseth, MD,
PhD from Oslo, Norway (see http://circ.ahajournals.org/
content/122/4/f19.full.pdf+html), and the late Cees Visser,
MD, from Amsterdam, he organised numerous postgradu-
ate courses on “diastology” at the European Society of
Cardiology Heart House in southern France. However,
Professor Paulus is probably best known as the European
lead editor of the textbook Cardiology.7
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Contact details for Professor Paulus: Laboratory of
Physiology and Institute for Cardiovascular Research VU
(ICaR-VU), VU University Medical Center, Van der
Boechorststraat 7, 1081 BT Amsterdam, The !etherlands.
Tel: 31 20 4448110. Fax: 31 20 4448255.
E-mail: wj.paulus@vumc.nl
Barry Shurlock is a freelance medical journalist.
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Left, Professor Paulus and his wife, Jackie, enjoy sailing in the sea arms of the southern !etherlands. Right, The MEDIA study group at
the kickoff meeting held in Amsterdam at VU University Medical Center on January 18, 2011. Photographs courtesy of Professor Paulus.
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